Ticker
ANABCompany Name
ANAPTYSBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
---|---|---|---|
6/30/2025 | $ -132.52M | $ 933.21M | 0 |
3/31/2025 | $ -140.58M | $ 856.38M | 0 |
12/31/2024 | $ -145.23M | $ 749.32M | 0 |
9/30/2024 | $ -165.65M | $ 780.4M | 0 |
6/30/2024 | $ -170.11M | $ 1.2B | 0 |
3/31/2024 | $ -163.3M | $ 990.45M | 0 |
12/31/2023 | $ -163.62M | $ 917.57M | 0 |
9/30/2023 | $ -147.8M | $ 733.73M | 0 |
6/30/2023 | $ -143.99M | $ 783.55M | 0 |
3/31/2023 | $ -136.7M | $ 781.89M | 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV / EBIT
(=) EV/EBIT
EV/EBIT for ANAPTYSBIO INC is calculated as follows: EV [ $ 601.1M ] / EBIT [ $ -73.66M ]
(=) EV/EBIT [ 0 ]
Minimum
Sep 30, 2021
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 2.25K |
---|---|
min | 0.05 |
max | 62.03 |
average | 19.91 |
median | 16.78 |
std | 12.32 |